GSK Gets Top Court Assist In MDL Victory 'Roadmap'
A sweeping order ending more than 400 cases alleging GlaxoSmithKline's anti-nausea medication Zofran causes birth defects provides a "roadmap" for fending off multidistrict litigation with the help of a landmark U.S....To view the full article, register now.
Already a subscriber? Click here to view full article